Can Rare Cancer Drugs Expect Sales in Japan?: A Prescription Pattern Analysis of Drugs for Chronic Myelogenous Leukemia and Neuroendocrine Tumor. (2019). Journal of Regulatory Science, 7, 1-9. https://doi.org/10.21423/JRS-V07SHIBATA